Cargando…
EVIR: Chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens
We describe a lentivirus-encoded chimeric receptor, termed extracellular vesicle (EV)-internalizing receptor (EVIR), which enables the selective uptake of cancer cell-derived EVs by dendritic cells (DCs). The EVIR enhances DC presentation of EV-associated tumor antigens to CD8(+) T cells primarily t...
Autores principales: | Squadrito, Mario Leonardo, Cianciaruso, Chiara, Hansen, Sarah K., De Palma, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833950/ https://www.ncbi.nlm.nih.gov/pubmed/29355847 http://dx.doi.org/10.1038/nmeth.4579 |
Ejemplares similares
-
Dendritic cell cross‐dressing and tumor immunity
por: Martinez‐Usatorre, Amaia, et al.
Publicado: (2022) -
Health funders’ dissemination and implementation practices: results from a survey of the Ensuring Value in Research (EViR) Funders’ Forum
por: van der Linden, Barbara, et al.
Publicado: (2022) -
Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells
por: Chan, Jack D, et al.
Publicado: (2020) -
Engineering Chimeric Antigen Receptors
por: Kulemzin, S. V., et al.
Publicado: (2017) -
Galunisertib enhances chimeric antigen receptor-modified T cell function
por: Wang, Zhixiong, et al.
Publicado: (2020)